Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms

Autor: Yongsoo Kim, Delin Chen, Ziedulla Abdullaev, Wei Gu, Alexander L. Kovalchuk, Jiafang Sun, Herbert C. Morse, Shao Xiang, William C. Cho, Siegfried Janz, Ted A. Torrey, Chen-Feng Qi
Jazyk: angličtina
Rok vydání: 2012
Předmět:
p53
CCCTC-Binding Factor
MYC
lcsh:Chemistry
Mice
0302 clinical medicine
Transcriptional regulation
Proto-Oncogene Proteins c-myc
ARF-BP1
B-cell lymphoma
CTCF
ARF
lcsh:QH301-705.5
Spectroscopy
0303 health sciences
biology
General Medicine
3. Good health
Computer Science Applications
Ubiquitin ligase
Gene Expression Regulation
Neoplastic

030220 oncology & carcinogenesis
Signal transduction
Signal Transduction
Lymphoma
B-Cell

Ubiquitin-Protein Ligases
Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
Downregulation and upregulation
Cell Line
Tumor

Animals
Humans
Physical and Theoretical Chemistry
Molecular Biology
030304 developmental biology
Tumor Suppressor Proteins
Organic Chemistry
HEK 293 cells
Wild type
Neoplasms
Experimental

Repressor Proteins
HEK293 Cells
lcsh:Biology (General)
lcsh:QD1-999
biology.protein
Cancer research
Tumor Suppressor Protein p53
Zdroj: International Journal of Molecular Sciences; Volume 13; Issue 5; Pages: 6204-6219
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 13, Iss 5, Pp 6204-6219 (2012)
ISSN: 1422-0067
DOI: 10.3390/ijms13056204
Popis: Transcriptional activation of MYC is a hallmark of many B cell lineage neoplasms. MYC provides a constitutive proliferative signal but can also initiate ARF-dependent activation of p53 and apoptosis. The E3 ubiquitin ligase, ARF-BP1, encoded by HUWE1, modulates the activity of both the MYC and the ARF-p53 signaling pathways, prompting us to determine if it is involved in the pathogenesis of MYC-driven B cell lymphomas. ARF-BP1 was expressed at high levels in cell lines from lymphomas with either wild type or mutated p53 but not in ARF-deficient cells. Downregulation of ARF-BP1 resulted in elevated steady state levels of p53, growth arrest and apoptosis. Co-immunoprecipitation studies identified a multiprotein complex comprised of ARF-BP1, ARF, p53, MYC and the multifunctional DNA-binding factor, CTCF, which is involved in the transcriptional regulation of MYC, p53 and ARF. ARF-BP1 bound and ubiquitylated CTCF leading to its proteasomal degradation. ARF-BP1 and CTCF thus appear to be key cofactors linking the MYC proliferative and p53-ARF apoptotic pathways. In addition, ARF-BP1 could be a therapeutic target for MYC-driven B lineage neoplasms, even if p53 is inactive, with inhibition reducing the transcriptional activity of MYC for its target genes and stabilizing the apoptosis-promoting activities of p53.
Databáze: OpenAIRE